Vulval cancer: prevention and screening
- Resource Type
- Authors
- Allan B. Maclean
- Source
- Best Practice & Research Clinical Obstetrics & Gynaecology. 20:379-395
- Subject
- medicine.medical_specialty
animal structures
Lichen sclerosus
Vulvar Lichen Sclerosus
Vulva
Patient Education as Topic
Terminology as Topic
medicine
Humans
Mass Screening
Pathological
Gynecology
Intraepithelial neoplasia
Vulvar Neoplasms
urogenital system
business.industry
Incidence (epidemiology)
fungi
Lichen Planus
Obstetrics and Gynecology
Vulval cancer
General Medicine
medicine.disease
Dermatology
female genital diseases and pregnancy complications
medicine.anatomical_structure
embryonic structures
Disease Progression
Etiology
Female
business
Vulval intraepithelial neoplasia
Precancerous Conditions
Carcinoma in Situ
- Language
- ISSN
- 1521-6934
The incidence of vulval cancer is rising, both in older women and those under 50 years of age. Vulval cancer has at least two types, one arising in association with lichen sclerosus (LS) and the other with vulval intraepithelial neoplasia (VIN). Recent pathological and aetiological descriptions are included, along with the latest description of VIN terminology. Prevention of and screening for vulval cancer will require greater understanding of why some women with LS and VIN are at greater risk: recent studies of molecular change might contribute to this. The use of vulval cytology and toluidine blue staining is described. Patient or vulval awareness may help but clinical features are non-specific. Prophylactic vaccination against HPV and campaigns against smoking may contribute in the future.